NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Orbus Therapeutics

Orbus Therapeutics

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://www.orbustherapeutics.com/

Last Round

Series A

Extension

Oct 22, 2020

Total Funding Raised

$71M

Company Overview

Orbus Therapeutics is a biopharmaceutical company that develops and commercializes therapeutic products for rare diseases, with a focus on treatments for brain tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaleflornithineanaplastic astrocytomarare diseaseorphan drugclinical trialbrain canceroncologydrug developmenttherapeutic candidatebiotechCNS cancerclinical-stagetargeted therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orbus Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Orbus Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Orbus Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionOct 22, 2020
Series AAug 19, 2015

Orbus Therapeutics Investors

Notable investors and investment history

Orbus Therapeutics investors
InvestorRounds
Longitude CapitalSeries A Extension, Series A
HIG BioHealth PartnersSeries A Extension, Series A
AbingworthSeries A Extension
Adams Street PartnersSeries A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 16, 2024

    Monthly visitors grew 118% MoM, reaching 1.6K.

Orbus Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Orbus Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orbus Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range3
Year Founded2012
Last FundingOct 22, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.